Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sentinel node biopsy for breast cancer.

L Tafra1

  • 1Breast Center, Anne Arundel Medical Center, Annapolis, Maryland, USA. ltafra@aahs.org

Minerva Chirurgica
|July 30, 2002
PubMed
Summary

Sentinel node biopsy is replacing axillary node dissection for cancer staging. This review covers techniques, influencing factors, and controversial areas in sentinel lymph node biopsy (SLNB) for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined pathologic-genomic algorithm for early-stage breast cancer improves cost-effective use of the 21-gene recurrence score assay.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

State of affairs of sentinel node biopsy for breast cancer.

Current surgery·2005
Same author

Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer.

American journal of surgery·2001
Same author

The learning curve and sentinel node biopsy.

American journal of surgery·2001
Same author

Comparison of intradermal and subcutaneous injections in lymphatic mapping.

The Journal of surgical research·2001
Same author

Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye.

Annals of surgery·2001

Area of Science:

  • Oncology
  • Surgical Pathology
  • Surgical Oncology

Background:

  • Sentinel lymph node biopsy (SLNB) is increasingly adopted, replacing axillary node dissection for accurate cancer staging.
  • Clinical trials demonstrate SLNB's efficacy in predicting disease presence in remaining lymph nodes.

Purpose of the Study:

  • To review current techniques, influencing factors, and controversial aspects of sentinel node biopsy.
  • To provide data supporting various SLNB techniques and discuss factors affecting identification and false negative rates.

Main Methods:

  • Comprehensive literature review of sentinel node biopsy techniques and outcomes.
  • Analysis of factors influencing sentinel node identification and false negative rates.

Main Results:

  • Sentinel node biopsy demonstrates high accuracy in predicting nodal status, reducing the need for complete axillary dissection.
  • Various techniques exist, with success rates influenced by factors like patient characteristics and surgical expertise.

Conclusions:

  • Sentinel node biopsy is a reliable alternative to axillary node dissection for staging cancer.
  • Key areas of controversy, including pathological analysis and specific applications like ductal carcinoma in situ, require further research and consensus.

Related Experiment Videos